Prenatal fat-rich diet exposure alters responses of embryonic neurons to the chemokine, CCL2, in the hypothalamus

Neuroscience

Volumn 324, Issue , 2016, Pages 407-419

  Poon, K ^a   Abramova, D ^a   Ho, H T ^a   Leibowitz, S ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

C C chemokine ligand 2 (CCL2); Enkephalin; Galanin; Hypothalamus; Migration; Prenatal high fat diet

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR4; ENKEPHALIN; GALANIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPEPTIDE; OREXIGENIC NEUROPEPTIDE; UNCLASSIFIED DRUG; CCL2 PROTEIN, RAT; CCR2 PROTEIN, RAT; CCR4 PROTEIN, RAT; FAT INTAKE; GAL PROTEIN, RAT; MESSENGER RNA; PROTEIN PRECURSOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CELL POPULATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FEMALE; GENE EXPRESSION REGULATION; HYPOTHALAMUS; LIPID DIET; LOW FAT DIET; MIGRATION INHIBITION; NERVE CELL; NERVE STIMULATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; UPREGULATION; ADVERSE EFFECTS; ANIMAL; CELL CULTURE; CELL MOTION; EMBRYOLOGY; FAT INTAKE; METABOLISM; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; SPRAGUE DAWLEY RAT;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; DIETARY FATS; ENKEPHALINS; FEMALE; GALANIN; HYPOTHALAMUS; NEURONS; PREGNANCY; PREGNANCY COMPLICATIONS; PROTEIN PRECURSORS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CCR2; RECEPTORS, CCR4; RNA, MESSENGER;

EID: 84961726956     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2016.03.017     Document Type: Article

References (63)

1. Ajram L., Begg M., Slack R., Cryan J., Hall D., Hodgson S., Ford A., Barnes A., Swieboda D., Mousnier A., Solari R. Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists. Eur J Pharmacol 2014, 729:75-85.
2. Akabayashi A., Koenig J.I., Watanabe Y., Alexander J.T., Leibowitz S.F. Galanin-containing neurons in the paraventricular nucleus: a neurochemical marker for fat ingestion and body weight gain. Proc Natl Acad Sci U S A 1994, 91:10375-10379.
3. Aragay A.M., Mellado M., Frade J.M., Martin A.M., Jimenez-Sainz M.C., Martinez A.C., Mayor F. Monocyte chemoattractant protein-1-induced CCR2B receptor desensitization mediated by the G protein-coupled receptor kinase 2. Proc Natl Acad Sci U S A 1998, 95:2985-2990.
4. Banisadr G., Queraud-Lesaux F., Boutterin M.C., Pelaprat D., Zalc B., Rostene W., Haour F., Parsadaniantz S.M. Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J Neurochem 2002, 81:257-269.
5. Banisadr G., Gosselin R.D., Mechighel P., Rostene W., Kitabgi P., Melik Parsadaniantz S. Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons. J Comp Neurol 2005, 492:178-192.
6. Barbarroja N., Lopez-Pedrera R., Mayas M.D., Garcia-Fuentes E., Garrido-Sanchez L., Macias-Gonzalez M., El Bekay R., Vidal-Puig A., Tinahones F.J. The obese healthy paradox: is inflammation the answer?. Biochem J 2010, 430:141-149.
7. Bouret S.G. Development of hypothalamic neural networks controlling appetite. Forum Nutr 2010, 63:84-93.
8. Carr M.W., Roth S.J., Luther E., Rose S.S., Springer T.A. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A 1994, 91:3652-3656.
9. Chang G.Q., Karatayev O., Ahsan R., Gaysinskaya V., Marwil Z., Leibowitz S.F. Dietary fat stimulates endogenous enkephalin and dynorphin in the paraventricular nucleus: role of circulating triglycerides. Am J Physiol Endocrinol Metab 2007, 292:E561-570.
10. Chang G.Q., Gaysinskaya V., Karatayev O., Leibowitz S.F. Maternal high-fat diet and fetal programming: increased proliferation of hypothalamic peptide-producing neurons that increase risk for overeating and obesity. J Neurosci 2008, 28:12107-12119.
11. Chang G.Q., Karatayev O., Leibowitz S.F. Prenatal exposure to ethanol stimulates hypothalamic CCR2 chemokine receptor system: possible relation to increased density of orexigenic peptide neurons and ethanol drinking in adolescent offspring. Neuroscience 2015, 310:163-175.
12. Chen A., Mumick S., Zhang C., Lamb J., Dai H., Weingarth D., Mudgett J., Chen H., MacNeil D.J., Reitman M.L., Qian S. Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes Res 2005, 13:1311-1320.
13. Chintawar S., Cayrol R., Antel J., Pandolfo M., Prat A. Blood-brain barrier promotes differentiation of human fetal neural precursor cells. Stem cells 2009, 27:838-846.
14. Craig M.J., Loberg R.D. CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases. Cancer Metast Rev 2006, 25:611-619.
15. Deng Y., Lu J., Sivakumar V., Ling E.A., Kaur C. Amoeboid microglia in the periventricular white matter induce oligodendrocyte damage through expression of proinflammatory cytokines via MAP kinase signaling pathway in hypoxic neonatal rats. Brain Pathol 2008, 18:387-400.
16. Dourmashkin J.T., Chang G.Q., Hill J.O., Gayles E.C., Fried S.K., Leibowitz S.F. Model for predicting and phenotyping at normal weight the long-term propensity for obesity in Sprague-Dawley rats. Physiol Behav 2006, 87:666-678.
17. Edman L.C., Mira H., Arenas E. The beta-chemokines CCL2 and CCL7 are two novel differentiation factors for midbrain dopaminergic precursors and neurons. Exp Cell Res 2008, 314:2123-2130.
18. Franciotta D., Martino G., Zardini E., Furlan R., Bergamaschi R., Andreoni L., Cosi V. Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. J Neuroimmunol 2001, 115:192-198.
19. Ge S., Pachter J.S. Caveolin-1 knockdown by small interfering RNA suppresses responses to the chemokine monocyte chemoattractant protein-1 by human astrocytes. J Biol Chem 2004, 279:6688-6695.
20. Gerhardt C.C., Romero I.A., Cancello R., Camoin L., Strosberg A.D. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 2001, 175:81-92.
21. Gosselin R.D., Varela C., Banisadr G., Mechighel P., Rostene W., Kitabgi P., Melik-Parsadaniantz S. Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones. J Neurochem 2005, 95:1023-1034.
22. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011, 29:415-445.
23. Guyon A., Conductier G., Rovere C., Enfissi A., Nahon J.L. Melanin-concentrating hormone producing neurons: activities and modulations. Peptides 2009, 30:2031-2039.
24. Guyon A., Skrzydelski D., De Giry I., Rovere C., Conductier G., Trocello J.M., Dauge V., Kitabgi P., Rostene W., Nahon J.L., Melik Parsadaniantz S. Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. Neuroscience 2009, 162:1072-1080.
25. He Y.Y., Du M.R., Guo P.F., He X.J., Zhou W.H., Zhu X.Y., Li D.J. Regulation of C-C motif chemokine ligand 2 and its receptor in human decidual stromal cells by pregnancy-associated hormones in early gestation. Hum Reprod 2007, 22:2733-2742.
26. Inouye K.E., Shi H., Howard J.K., Daly C.H., Lord G.M., Rollins B.J., Flier J.S. Absence of CC chemokine ligand 2 does not limit obesity-associated infiltration of macrophages into adipose tissue. Diabetes 2007, 56:2242-2250.
27. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Investig 2006, 116:1494-1505.
28. Kao D.J., Li A.H., Chen J.C., Luo R.S., Chen Y.L., Lu J.C., Wang H.L. CC chemokine ligand 2 upregulates the current density and expression of TRPV1 channels and Nav1.8 sodium channels in dorsal root ganglion neurons. J Neuroinflamm 2012, 9:189.
29. Kyrkouli S.E., Stanley B.G., Seirafi R.D., Leibowitz S.F. Stimulation of feeding by galanin: anatomical localization and behavioral specificity of this peptide's effects in the brain. Peptides 1990, 11:995-1001.
30. Liu X.S., Zhang Z.G., Zhang R.L., Gregg S.R., Wang L., Yier T., Chopp M. Chemokine ligand 2 (CCL2) induces migration and differentiation of subventricular zone cells after stroke. J Neurosci Res 2007, 85:2120-2125.
31. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., North R., Gerard C., Rollins B.J. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998, 187:601-608.
32. Magge S.N., Malik S.Z., Royo N.C., Chen H.I., Yu L., Snyder E.Y., O'Rourke D.M., Watson D.J. Role of monocyte chemoattractant protein-1 (MCP-1/CCL2) in migration of neural progenitor cells toward glial tumors. J Neurosci Res 2009, 87:1547-1555.
33. Mahad D., Callahan M.K., Williams K.A., Ubogu E.E., Kivisakk P., Tucky B., Kidd G., Kingsbury G.A., Chang A., Fox R.J., Mack M., Sniderman M.B., Ravid R., Staugaitis S.M., Stins M.F., Ransohoff R.M. Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis. Brain 2006, 129:212-223.
34. Markakis E.A. Development of the neuroendocrine hypothalamus. Front Neuroendocrinol 2002, 23:257-291.
35. Matsushima K., Larsen C.G., DuBois G.C., Oppenheim J.J. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989, 169:1485-1490.
36. Melgarejo E., Medina M.A., Sanchez-Jimenez F., Urdiales J.L. Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol 2009, 41:998-1001.
37. Meng S.Z., Oka A., Takashima S. Developmental expression of monocyte chemoattractant protein-1 in the human cerebellum and brainstem. Brain Develop 1999, 21:30-35.
38. Meucci O., Fatatis A., Simen A.A., Bushell T.J., Gray P.W., Miller R.J. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci U S A 1998, 95:14500-14505.
39. Milanski M., Degasperi G., Coope A., Morari J., Denis R., Cintra D.E., Tsukumo D.M., Anhe G., Amaral M.E., Takahashi H.K., Curi R., Oliveira H.C., Carvalheira J.B., Bordin S., Saad M.J., Velloso L.A. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci 2009, 29:359-370.
40. Murabayashi N., Sugiyama T., Zhang L., Kamimoto Y., Umekawa T., Ma N., Sagawa N. Maternal high-fat diets cause insulin resistance through inflammatory changes in fetal adipose tissue. Eur J Obstet Gynecol Reprod Biol 2013, 169:39-44.
41. Naleid A.M., Grace M.K., Chimukangara M., Billington C.J., Levine A.S. Paraventricular opioids alter intake of high-fat but not high-sucrose diet depending on diet preference in a binge model of feeding. Am J Physiol Regul Integr Comp Physiol 2007, 293:R99-105.
42. Poon K., Barson J.R., Fagan S.E., Leibowitz S.F. Developmental changes in embryonic hypothalamic neurons during prenatal fat exposure. Am J Physiol Endocrinol Metab 2012, 303:E432-441.
43. Poon K., Mandava S., Chen K., Barson J.R., Buschlen S., Leibowitz S.F. Prenatal exposure to dietary fat induces changes in the transcriptional factors, TEF and YAP, which may stimulate differentiation of peptide neurons in rat hypothalamus. PLoS One 2013, 8:e77668.
44. Poon K., Ho H.T., Barson J.R., Leibowitz S.F. Stimulatory role of the chemokine CCL2 in the migration and peptide expression of embryonic hypothalamic neurons. J Neurochem 2014, 131:509-520.
45. Reynolds C.M., Vickers M.H., Harrison C.J., Segovia S.A., Gray C. High fat and/or high salt intake during pregnancy alters maternal meta-inflammation and offspring growth and metabolic profiles. Physiol Rep 2014, 2.
46. Reynolds C.M., Vickers M.H., Harrison C.J., Segovia S.A., Gray C. Maternal high fat and/or salt consumption induces sex-specific inflammatory and nutrient transport in the rat placenta. Physiol Rep 2015, 3.
47. Rezaie P., Trillo-Pazos G., Everall I.P., Male D.K. Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS. Glia 2002, 37:64-75.
48. Rollins B.J. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 1996, 2:198-204.
49. Rollins B.J., Walz A., Baggiolini M. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 1991, 78:1112-1116.
50. Rull A., Camps J., Alonso-Villaverde C., Joven J. Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism. Mediators Inflamm 2010.
51. Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012, 9:671-675.
52. Segovia S.A., Vickers M.H., Gray C., Reynolds C.M. Maternal obesity, inflammation, and developmental programming. Biomed Res Int 2014, 418975.
53. Sorensen T.L., Sellebjerg F., Jensen C.V., Strieter R.M., Ransohoff R.M. Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis. Eur J Neurol 2001, 8:665-672.
54. Stachowiak E.K., Srinivasan M., Stachowiak M.K., Patel M.S. Maternal obesity induced by a high fat diet causes altered cellular development in fetal brains suggestive of a predisposition of offspring to neurological disorders in later life. Metab Brain Dis 2013, 28:721-725.
55. Takanabe-Mori R., Ono K., Sowa N., Wada H., Takaya T., Horie T., Satoh-Asahara N., Shimatsu A., Fujita M., Sawamura T., Hasegawa K. Lectin-like oxidized low-density lipoprotein receptor-1 is required for the adipose tissue expression of proinflammatory cytokines in high-fat diet-induced obese mice. Biochem Biophys Res Commun 2010, 398:576-580.
56. Tylaska L.A., Boring L., Weng W., Aiello R., Charo I.F., Rollins B.J., Gladue R.P. Ccr2 regulates the level of MCP-1/CCL2 in vitro and at inflammatory sites and controls T cell activation in response to alloantigen. Cytokine 2002, 18:184-190.
57. Volpe S., Cameroni E., Moepps B., Thelen S., Apuzzo T., Thelen M. CCR2 acts as scavenger for CCL2 during monocyte chemotaxis. PLoS ONE 2012, 7:e37208.
58. Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., Charo I., Leibel R.L., Ferrante A.W. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Investig 2006, 116:115-124.
59. Yan X., Huang Y., Wang H., Du M., Hess B.W., Ford S.P., Nathanielsz P.W., Zhu M.J. Maternal obesity induces sustained inflammation in both fetal and offspring large intestine of sheep. Inflamm Bowel Dis 2011, 17:1513-1522.
60. Yoshimura T., Robinson E.A., Tanaka S., Appella E., Kuratsu J., Leonard E.J. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med 1989, 169:1449-1459.
61. Zhang Y., Rollins B.J. A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer. Mol Cell Biol 1995, 15:4851-4855.
62. Zhang N., Rogers T.J., Caterina M., Oppenheim J.J. Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons. J Immunol 2004, 173:594-599.
63. Zhou Y., Tang H., Liu J., Dong J., Xiong H. Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices. J Neurochem 2011, 116:406-414.